Categories: Public Companies

Prestige Consumer Healthcare Inc. to Release Fiscal 2020 Second Quarter Earnings Results

TARRYTOWN, N.Y., Oct. 02, 2019 (GLOBE NEWSWIRE) — Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2020 second quarter earnings release on Thursday, October 31, 2019 before the opening of the market. The Company will host a conference call to discuss the results that same morning at 8:30 a.m. ET.

To access the call, listeners calling from within North America may dial 844-233-9440 about 15 minutes prior to the start of the call. Those wishing to access the call from outside North America should dial 574-990-1016. The conference ID is 7237807. The Company will provide a live Internet webcast as well as an archived replay, which can be accessed from the Investor Relations page of www.prestigeconsumerhealthcare.com.

Telephonic replays will be available for one week following completion of the live call and can be accessed at 855-859-2056 within North America, and at 404-537-3406 from outside North America. The conference ID is 7237807.

About Prestige Consumer Healthcare Inc.

Prestige Consumer Healthcare markets, sells, manufactures and distributes consumer healthcare products to retail outlets throughout the U.S. and Canada, Australia, and in certain other international markets. The Company’s diverse portfolio of brands include Monistat® and Summer’s Eve® women’s health products, BC® and Goody’s® pain relievers, Clear Eyes® eye care products, DenTek® specialty oral care products, Dramamine® motion sickness treatments, Fleet® enemas and glycerin suppositories, Chloraseptic® and Luden’s® sore throat treatments and drops, Compound W® wart treatments, Little Remedies® pediatric over-the-counter products, Boudreaux’s Butt Paste® diaper rash ointments, Nix® lice treatment, Debrox® earwax remover, Gaviscon® antacid in Canada, and Hydralyte® rehydration products and the Fess® line of nasal and sinus care products in Australia. Visit the Company’s website at www.prestigeconsumerhealthcare.com.

Investor Relations Contact

Phil Terpolilli, 914-524-6819

irinquiries@prestigebrands.com

IR Press

Share
Published by
IR Press

Recent Posts

Treasury Sanctions Entities in Iran and Russia That Attempted to Interfere in the U.S. 2024 Election

WASHINGTON – Today, the Department of the Treasury’s Office of Foreign Assets Control (OFAC) is…

22 hours ago

Treasury Sanctions Russian Judge for Arbitrary Detention of Alexei Gorinov

WASHINGTON – Today, the U.S. Department of the Treasury’s Office of Foreign Assets Control (OFAC)…

22 hours ago

U.S. Department of the Treasury Releases Final Regulations Implementing Bipartisan Tax Reporting Requirements for Brokers of Digital Assets

Regulations help make filing easier for digital asset holders on taxes already owed WASHINGTON – As part of…

5 days ago

OCC Issues Annual Report for 2024

WASHINGTON—The Office of the Comptroller of the Currency (OCC) today published its 2024 Annual Report.…

2 weeks ago

OCC Announces Enforcement Actions for December 2024

WASHINGTON—The Office of the Comptroller of the Currency (OCC) today released enforcement actions taken against…

2 weeks ago

Treasury Maintains Pressure on Houthi Procurement and Financing Schemes

WASHINGTON — Today, the Department of the Treasury’s Office of Foreign Assets Control (OFAC) sanctioned…

2 weeks ago